Jorge Eduardo Cortés
Arzt,
Onkologe,
Hochschullehrer
Geboren:
197X
Hat mitgewirkt an:
-
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
-
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
-
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
-
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia